Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.795
+0.075 (1.59%)
Jun 4, 2026, 9:36 AM EDT - Market open
Nuvation Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -145.99 | -204.63 | -567.94 | -75.8 | -104.2 | -86.85 |
Depreciation & Amortization | 1.97 | 1.74 | 0.68 | 0.22 | 0.2 | 0.18 |
Stock-Based Compensation | 37.07 | 35.89 | 32.28 | 19.51 | 16.29 | 9.27 |
Other Adjustments | 7.44 | 5.55 | 417.05 | -12.47 | -4.95 | 4.41 |
Change in Receivables | -22.31 | -3.35 | -12.72 | - | - | - |
Changes in Inventories | -15.83 | -11.41 | - | - | - | - |
Changes in Accounts Payable | 11.9 | 3.13 | -1.65 | 0.07 | -1.79 | 1.86 |
Changes in Accrued Expenses | 8.97 | 12.35 | 6.84 | -0.02 | -2.32 | 7.45 |
Changes in Unearned Revenue | -5.99 | -7.87 | 3.94 | - | - | - |
Changes in Other Operating Activities | -6.97 | -4.83 | -8.91 | 0.49 | 0.66 | -4.52 |
Operating Cash Flow | -125.73 | -173.43 | -130.41 | -68 | -96.11 | -68.19 |
Capital Expenditures | -0.33 | -0.35 | -0.16 | -0.07 | -0.37 | -0.28 |
Sale of Property, Plant & Equipment | - | - | - | 0.01 | 0.01 | - |
Purchases of Intangible Assets | - | -8 | - | - | - | - |
Purchases of Investments | -375.86 | -354.42 | -339.65 | -703.37 | -520.31 | -609.3 |
Proceeds from Sale of Investments | 385.89 | 462.29 | 450.08 | 712.35 | 584.12 | 154.91 |
Other Investing Activities | - | - | 12.43 | - | - | - |
Investing Cash Flow | 1.7 | 99.52 | 122.7 | 8.92 | 63.46 | -454.67 |
Long-Term Debt Issued | 110.65 | 210.1 | 12.61 | - | - | - |
Long-Term Debt Repaid | -12.65 | -12.39 | -17.16 | - | - | - |
Net Long-Term Debt Issued (Repaid) | 98 | 197.71 | -4.55 | - | - | - |
Issuance of Common Stock | 10.98 | 11.42 | 4.89 | 0.63 | 1.33 | 625.53 |
Net Common Stock Issued (Repurchased) | 10.98 | 11.42 | 4.89 | 0.63 | 1.33 | 625.53 |
Other Financing Activities | -3.29 | -6.6 | - | - | - | - |
Financing Cash Flow | 202.03 | 202.54 | 0.33 | 0.63 | 1.33 | 625.53 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.59 | -0.27 | 0.45 | - | - | - |
Net Cash Flow | 77.41 | 128.36 | -6.93 | -58.45 | -31.32 | 102.67 |
Free Cash Flow | -126.06 | -173.78 | -130.58 | -68.07 | -96.48 | -68.47 |
FCF Margin | -88.13% | -276.27% | -1658.52% | - | - | - |
Free Cash Flow Per Share | -0.36 | -0.51 | -0.49 | -0.31 | -0.45 | -0.35 |
Levered Free Cash Flow | -54.28 | -14.16 | -571.76 | -75.11 | -107.82 | -82.15 |
Unlevered Free Cash Flow | -156.47 | -220.3 | -591.89 | -99.13 | -123.35 | -88.62 |